Telogen Effluvium Medication

1. Poonia K, Thami GP, Bhalla M, Jaiswal S, Sandhu J. NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India. J Cosmet Dermatol. 2018 May 17. [QxMD MEDLINE Link].

2. Sinclair R. Chronic telogen effluvium: a study of 5 patients over 7 years. J Am Acad Dermatol. 2005 Feb. 52(2 Suppl 1):12-6. [QxMD MEDLINE Link].

3. Whiting DA. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol. 1996 Dec. 35(6):899-906. [QxMD MEDLINE Link].

4. Perez-Mora N, Goren A, Velasco C, Bermudez F. Acute telogen effluvium onset event is associated with the presence of female androgenetic alopecia: potential therapeutic implications. Dermatol Ther. 2014 May-Jun. 27(3):159-62. [QxMD MEDLINE Link].

5. Headington JT. Telogen effluvium. New concepts and review. Arch Dermatol. 1993 Mar. 129(3):356-63. [QxMD MEDLINE Link].

6. Hadshiew IM, Foitzik K, Arck PC, Paus R. Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol. 2004 Sep. 123(3):455-7. [QxMD MEDLINE Link].

7. Peters EM, Liotiri S, Bodo E, et al. Probing the effects of stress mediators on the human hair follicle: substance P holds central position. Am J Pathol. 2007 Dec. 171(6):1872-86. [QxMD MEDLINE Link].

8. Padovese V, Racalbuto V, Barnabas GA, Morrone A. Operational research on the correlation between skin diseases and HIV infection in Tigray region, Ethiopia. Int J Dermatol. 2015 Oct. 54 (10):1169-74. [QxMD MEDLINE Link].

9. Barcaui CB, Gonçalves da Silva AM, Sotto MN, Genser B. Stem cell apoptosis in HIV-1 alopecia. J Cutan Pathol. 2006 Oct. 33(10):667-71. [QxMD MEDLINE Link].

10. Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R. Telogen Effluvium: A Review of the Literature. Cureus. 2020 May 27. 12 (5):e8320. [QxMD MEDLINE Link].

11. Turkmen D, Altunisik N, Sener S, Colak C. Evaluation of the effects of COVID-19 pandemic on hair diseases through a web-based questionnaire. Dermatol Ther. 2020 Jun 28. e13923. [QxMD MEDLINE Link].

12. Hughes EC, Saleh D. Telogen Effluvium. StatPearls [Internet]. 2020 Jan. [QxMD MEDLINE Link]. [Full Text].

13. Freinkel RK, Freinkel N. Hair growth and alopecia in hypothyroidism. Arch Dermatol. 1972 Sep. 106(3):349-52. [QxMD MEDLINE Link].

14. Goette DK, Odom RB. Alopecia in crash dieters. JAMA. 1976 Jun 14. 235(24):2622-3. [QxMD MEDLINE Link].

15. Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol. 2003 Nov. 121(5):985-8. [QxMD MEDLINE Link].

16. Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. 2006 May. 54(5):824-44. [QxMD MEDLINE Link].

17. Malkud S. A Hospital-based Study to Determine Causes of Diffuse Hair Loss in Women. J Clin Diagn Res. 2015 Aug. 9 (8):WC01-4. [QxMD MEDLINE Link].

18. Olsen EA, Reed KB, Cacchio PB, Caudill L. Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. J Am Acad Dermatol. 2010 Dec. 63(6):991-9. [QxMD MEDLINE Link].

19. Brodin MB. Drug-related alopecia. Dermatol Clin. 1987 Jul. 5(3):571-9. [QxMD MEDLINE Link].

20. Wise RP, Kiminyo KP, Salive ME. Hair loss after routine immunizations. JAMA. 1997 Oct 8. 278(14):1176-8. [QxMD MEDLINE Link].

21. Katz KA, Cotsarelis G, Gupta R, Seykora JT. Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson's disease. J Am Acad Dermatol. 2006 Nov. 55(5 Suppl):S103-4. [QxMD MEDLINE Link].

22. Tosti A, Piraccini BM, van Neste DJ. Telogen effluvium after allergic contact dermatitis of the scalp. Arch Dermatol. 2001 Feb. 137(2):187-90. [QxMD MEDLINE Link].

23. Cartwright T, Endean N, Porter A. Illness perceptions, coping and quality of life in patients with alopecia. Br J Dermatol. 2009 May. 160(5):1034-9. [QxMD MEDLINE Link].

24. Schmidt S, Fischer TW, Chren MM, Strauss BM, Elsner P. Strategies of coping and quality of life in women with alopecia. Br J Dermatol. 2001 May. 144(5):1038-43. [QxMD MEDLINE Link].

25. Martínez-Velasco MA, Vázquez-Herrera NE, Maddy AJ, Asz-Sigall D, Tosti A. The Hair Shedding Visual Scale: A Quick Tool to Assess Hair Loss in Women. Dermatol Ther (Heidelb). 2017 Mar. 7 (1):155-165. [QxMD MEDLINE Link].

26. Jain N, Doshi B, Khopkar U. Trichoscopy in alopecias: diagnosis simplified. Int J Trichology. 2013 Oct. 5(4):170-8. [QxMD MEDLINE Link]. [Full Text].

27. McDonald KA, Shelley AJ, Colantonio S, Beecker J. Hair pull test: Evidence-based update and revision of guidelines. J Am Acad Dermatol. 2017 Mar. 76 (3):472-477. [QxMD MEDLINE Link].

28. Sinclair R, Jolley D, Mallari R, Magee J. The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair loss in women. J Am Acad Dermatol. 2004 Aug. 51(2):189-99. [QxMD MEDLINE Link].

29. Rebora A, Guarrera M, Baldari M, Vecchio F. Distinguishing androgenetic alopecia from chronic telogen effluvium when associated in the same patient: a simple noninvasive method. Arch Dermatol. 2005 Oct. 141(10):1243-5. [QxMD MEDLINE Link].

30. Ross EK, Vincenzi C, Tosti A. Videodermoscopy in the evaluation of hair and scalp disorders. J Am Acad Dermatol. 2006 Nov. 55(5):799-806. [QxMD MEDLINE Link].

31. Kinoshita-Ise M, Fukuyama M, Ohyama M. Color-transition sign: A useful trichoscopic finding for differentiating alopecia areata incognita from telogen effluvium. J Dermatol. 2018 Mar 6. [QxMD MEDLINE Link].

32. Randolph M, Tosti A. Oral minoxidil treatment for hair loss: A review of efficacy and safety. J Am Acad Dermatol. 2020 Jul 1. [QxMD MEDLINE Link].

33. Sharma AN, Michelle L, Juhasz M, Muller Ramos P, Atanaskova Mesinkovska N. Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review. Int J Dermatol. 2020 Aug. 59 (8):1013-1019. [QxMD MEDLINE Link].

Elizabeth CW Hughes, MD Dermatologist, Group Health Cooperative

Elizabeth CW Hughes, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association

Disclosure: Nothing to disclose.

David F Butler, MD Former Section Chief of Dermatology, Central Texas Veterans Healthcare System; Professor of Dermatology, Texas A&M University College of Medicine; Founding Chair, Department of Dermatology, Scott and White Clinic

David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, Association of Military Dermatologists, Phi Beta Kappa, Texas Dermatological Society

Disclosure: Nothing to disclose.

Edward F Chan, MD Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania School of Medicine

Edward F Chan, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, Society for Investigative Dermatology

Disclosure: Nothing to disclose.

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Leonard Sperling, MD Chair, Professor, Department of Dermatology, Uniformed Services University of the Health Sciences

Leonard Sperling, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article